The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 39.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 57% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
KIOXIA HOLDINGS CORPORATION
285A.T · UNKNOWN · JPY · Market cap $27.96T
Kioxia Holdings Corporation manufactures and sells memory and solid-state drives (SSDs) in Japan and internationally.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 20:08 UTC · 15 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price9,091.00 JPY at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.75x the price, above our 1.35x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
KIOXIA HOLDINGS CORPORATION holds its Distribution at $9,091.00. Consolidating, no directional conviction, held for 9 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 9 days |
| Price at the screen | $9,091.00 |
| Valuation | 21.00 trailing · N/A forward price to earnings |
| Values screen | FAIL |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 33.96% | Below 33% | Interest-bearing debt is 34.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 5.94% | Below 33% | Cash held in interest-bearing accounts and securities is 5.9% of assets, under the one-third limit. | Pass |
| Receivables | 30.66% | Below 49% | Money owed to the company is 30.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.41% | Below 5% | Only 0.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
KIOXIA HOLDINGS CORPORATION's business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when 285A.T's ethical verdict changes
Today 285A.T does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.75x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 16 covering, consensus Buy. The average target sits +307% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Trailing P/E | 21.0xa premium valuation |
| EPS, trailing | 833.50 |
| Revenue growth | +415.5%growing very fast |
| Profit margin | 36.6%highly profitable on every dollar of sales |
| Return on equity | 87.1%an exceptional return on shareholder capital |
| FCF yield | 3.07% |
| Debt to equity | 0.35minimal debt: a conservative balance sheet |
| Current ratio | 1.77healthy short-term liquidity |
| 52-week range | 1,950.00 - 37,566.67 |
| Moat | MODERATE |
| Market cap | $27.96T |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade285A.T trades on UNKNOWN (the company is based in Japan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 57% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 72.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 56% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 269% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 3207%. Our forward projection puts the odds of a 10% gain over the next month near 69%. The street (15 analysts) rates it buy, with a mean price target of $60327. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Japanese chipmakers rally as Micron earnings boost AI trade Yahoo Finance · 1 Oct 2026
- Asia stocks rise on chipmaker gains, soft U.S. inflation; Nikkei outperforms Yahoo Finance · 1 Oct 2026
- Asia chip stocks slide as OpenAI pause revives AI slowdown fears Investing.com · 28 Sep 2026
- Asia chip stocks slide as OpenAI pause revives AI slowdown fears Yahoo Finance · 28 Sep 2026
- European Stocks Fall at Open as Banks, Tech Slide The Wall Street Journal · 24 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $45,940.00 | +53.5% | · | $1,535 | +53.5% |
| 2 months | $30,140.00 | +133.9% | · | $2,339 | +133.9% |
| 3 months | $21,245.00 | +231.8% | · | $3,318 | +231.8% |
| 6 months | $9,890.00 | +612.8% | · | $7,128 | +612.8% |
| 1 year | $2,132.00 | +3,206.8% | · | $33,068 | +3,206.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 285A.T does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.